BRF
IBB icon

B. Riley Financial’s iShares Biotechnology ETF IBB Stock Holding History

B. Riley Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,355
Closed -$775K – 143
2018
Q3 		$775K Sell
6,355
-363
-5% -$42.7K 0.22% 72
2018
Q2 		$739K Buy
6,718
+112
+2% +$12K 0.19% 98
2018
Q1 		$706K Hold
6,606
– – 0.2% 121
2017
Q4 		$706K Buy
6,606
+249
+4% +$26.6K 0.18% 130
2017
Q3 		$707K Buy
6,357
+15
+0.2% +$1.6K 0.19% 128
2017
Q2 		$656K Hold
6,342
– – 0.18% 115
2017
Q1 		$620K Buy
6,342
+639
+11% +$61.2K 0.31% 68
2016
Q4 		$504K Buy
5,703
+1,347
+31% +$123K 0.34% 66
2016
Q3 		$420K Buy
4,356
+315
+8% +$30K 0.27% 65
2016
Q2 		$347K Buy
4,041
+210
+5% +$18.8K 0.2% 68
2016
Q1 		$333K Buy
3,831
+1,065
+39% +$95.2K 0.24% 65
2015
Q4 		$312K Buy
+2,766
New +$300K 0.22% 73

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

B. Riley Financial's IBB Position: Q4 2018 in Review

B. Riley Financial sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 6,355 shares — an estimated $775K sold.

B. Riley Financial first reported a position in IBB in Q4 2015 and held it in 12 quarters. The position peaked at $775K in Q3 2018. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

  • B. Riley Financial reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
  • B. Riley Financial sold 6,355 iShares Biotechnology ETF shares in Q4 2018, an estimated $775K.
  • B. Riley Financial first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 12 quarters.
  • B. Riley Financial's iShares Biotechnology ETF position peaked at $775K in Q3 2018.
  • 649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on B. Riley Financial's 13F filing for Q4 2018, filed 7 Feb 2019.